Toujeo is a long-acting insulin used to help manage blood sugar levels in people with diabetes. It contains insulin glargine, a modified form of human insulin. Toujeo is typically prescribed for adults and children aged six years and older with type 1 or type 2 diabetes. It helps provide steady and long-lasting blood sugar control, often requiring just one injection per day.
Mechanism of Action
Toujeo works by mimicking the action of natural insulin, which helps move sugar from the blood into the body’s cells for energy. Once injected, the insulin glargine forms tiny deposits under the skin. These deposits slowly release insulin over a 24-hour period, providing a consistent effect throughout the day and night.
By keeping blood sugar stable, Toujeo helps prevent both high and low sugar levels, reducing the risk of long-term complications of diabetes.
Uses
Toujeo is used for:
-
Managing type 1 diabetes, where the body makes little or no insulin
-
Controlling blood sugar in type 2 diabetes, where the body’s insulin does not work properly
-
Helping prevent complications such as nerve damage, kidney disease, and vision problems caused by high blood sugar
-
Providing a once-daily long-acting insulin option that can be used along with short-acting insulin or oral diabetes medicines
Adverse Effects
Toujeo is usually well tolerated, but some side effects can occur:
-
Low blood sugar, or hypoglycemia, is the most common and serious side effect. Symptoms include sweating, shaking, dizziness, and confusion.
-
Weight gain, which may happen due to better sugar control
-
Mild injection site reactions like redness, swelling, or itching
-
In rare cases, allergic reactions to insulin or preservatives
-
Changes in fat tissue under the skin when injected in the same spot repeatedly
-